River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

Bernstein raised the firm’s price target on Elevance Health (ELV) to $585 from $511 and keeps an Outperform rating on the shares. The firm sees ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Buying $100 In ELV: If an investor had bought $100 of ELV stock 15 years ago, it would be worth $667.52 today based on a ...

U.S. health benefits company Elevance Health ... Based on short-term price targets offered by 19 analysts, the Wall Street average price target is at $485.13 per share, suggesting a 15.25% ...

Health insurers received duplicate payments from the Medicaid system for covering hundreds of thousands of patients nationwide, leading to ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.09%, which ...

Elevance Health Inc. closed 24.10% below its 52-week high of $567.26, which the company achieved on September 3rd.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...